The illicit e-vapour trade presents a challenge to legally distributed products in the Middle East. Successfully navigating the e-vapour market in the Middle East requires a thorough understanding of these challenges and a strategic approach that allows brands to mitigate the illicit trade risk.
The laws and regulations regarding cannabis in Japan have undergone significant changes in recent years. In particular, in 2023, a revised bill was proposed for the Cannabis Control Law, which established a new offence for use and officially approved Epidiolex, a CBD preparation for medical use. The revised law was delayed from the initially scheduled date of October 2024, and then came into effect on 12 December, but expectations for growth in the CBD market temporarily slowed in 2024. This article explains the reasons for this, the current situation, and the outlook for the future market.
The nicotine industry is undergoing significant changes as it adapts to evolving consumer preferences and regulatory landscapes. While traditional cigarette smoking continues to decline, new trends are emerging that shape the future of nicotine consumption. Here we take a look at the top five trends in nicotine for 2025.
Globally, legal e-vapour products are set to grow at a notably slower pace in volume than in previous years, trailing behind nicotine pouches and heated tobacco. However, this growth figure only scratches the surface of the e-vapour market, as non-compliant and illicit products continue to surge in popularity worldwide.
Increased lifestyle fragmentation, pressure for productivity, along with a desire for optimisation and self-stability are resulting in strong growth in the importance of a need states mindset among consumers seeking to bring precision and effectiveness to their consumption.
While legalization remains a major hurdle, increasing cannabis usage can influence consumer habits and behaviour, on interconnected categories. For industries such as nicotine, pharmaceuticals, alcohol, and supplements, open questions remain as to the impact on sales and market penetration in the forecast period. In other words, is cannabis seen as a replacement?